Introduction. - The neutrophil to lymphocyte ratio (NLR) and the platelet to lymphocyte ratio (PLR) are established markers of systemic inflammation. Moreover, anemia is a known adverse prognostic factor and reduced haemoglobin to platelet ratio (HPR) seems associate to poor outcomes in urothelial cancer. Aim of the current study was to explore the prognostic value of NLR, HPR and PLR in patients harboring localized RCC.Materials and Methods 184 patients undergoing partial and radical nephrectomy for renal mass in a single hospital were retrospectively analyzed. Uni- and multivariate logistic regressions were performed to assess associations between various risk factors, including NLR, PLR and HPR and locally advanced disease (<= pT2 vs. >= pT3) and tumor grade. Kaplan Meier curves and Cox regressions were constructed to assess the association of NLR, PLR and HPR to recurrence free survival (RFS), cancer specific survival (CSS) and overall survival (OS). To determine thresholds for variables, we considered the 75th percentile of our distribution of values, which was computed at 3.45 for NLR, 189 for PLR and 0.48 for HPR. A two-sided P < 0.05 defined statistical significance.Results. - Patients with an elevated NLR (> 3.45) were more likely to present with >= pT3 stage (p = 0.046). RFS was significantly different according to NLR value, with patients having an NLR > 3.45 experiencing significantly worst RFS (P = 0.019); similarly, an increased PLR was significantly associated to a reduced RFS (P = 0.012). Restricting the Cox regression to patients with locally advanced disease (>= pT3), NLR was even more associated to recurrence (HR 3.22; 95%CI: 1.06-9.81, P = 0.039). Patients exhibiting an NLR > 3.45 (p = 0.03) or a PLR> 189 (P = 0.005) did have a significantly worse CSS, while a HPR < 0.48 did not predict CSS (P = 0.12) on Kaplan Meier curves. Finally, an increased NLR (P = 0.047), increased PLR (P = 0.0006) and decreased HPR (P = 0.05) were all associated to a poor overall survival on univariate analysis. On multivariate analysis, only HPR remained significantly predictive of OS (HR 0.077; 95%CI: 0.02-0.37, P = 0.001).Conclusions. - In this single -center study analyzing non-metastatic RCC, an increased NLR was significantly associated to a reduced RFS, CSS and OS on univariate analyses and to RFS on multivariate analysis. Larger prospective studies are needed to validate our findings.

Albisinni, S., Pretot, D., Al Hajj Obeid, W., Aoun, F., Quackels, T., Peltier, A., et al. (2019). The impact of neutrophil-to-lymphocyte, platelet-to-lymphocyte and haemoglobin-to-platelet ratio on localised renal cell carcinoma oncologic outcomes|L'impact du rapport neutrophiles-lymphocytes, plaquettes-lymphocytes et hémoglobine-plaquettes sur les résultats oncologiques du carcinome rénal localisés. PROGRES EN UROLOGIE, 29(8-9), 423-431 [10.1016/j.purol.2019.05.008].

The impact of neutrophil-to-lymphocyte, platelet-to-lymphocyte and haemoglobin-to-platelet ratio on localised renal cell carcinoma oncologic outcomes|L'impact du rapport neutrophiles-lymphocytes, plaquettes-lymphocytes et hémoglobine-plaquettes sur les résultats oncologiques du carcinome rénal localisés

Albisinni S.;
2019-01-01

Abstract

Introduction. - The neutrophil to lymphocyte ratio (NLR) and the platelet to lymphocyte ratio (PLR) are established markers of systemic inflammation. Moreover, anemia is a known adverse prognostic factor and reduced haemoglobin to platelet ratio (HPR) seems associate to poor outcomes in urothelial cancer. Aim of the current study was to explore the prognostic value of NLR, HPR and PLR in patients harboring localized RCC.Materials and Methods 184 patients undergoing partial and radical nephrectomy for renal mass in a single hospital were retrospectively analyzed. Uni- and multivariate logistic regressions were performed to assess associations between various risk factors, including NLR, PLR and HPR and locally advanced disease (<= pT2 vs. >= pT3) and tumor grade. Kaplan Meier curves and Cox regressions were constructed to assess the association of NLR, PLR and HPR to recurrence free survival (RFS), cancer specific survival (CSS) and overall survival (OS). To determine thresholds for variables, we considered the 75th percentile of our distribution of values, which was computed at 3.45 for NLR, 189 for PLR and 0.48 for HPR. A two-sided P < 0.05 defined statistical significance.Results. - Patients with an elevated NLR (> 3.45) were more likely to present with >= pT3 stage (p = 0.046). RFS was significantly different according to NLR value, with patients having an NLR > 3.45 experiencing significantly worst RFS (P = 0.019); similarly, an increased PLR was significantly associated to a reduced RFS (P = 0.012). Restricting the Cox regression to patients with locally advanced disease (>= pT3), NLR was even more associated to recurrence (HR 3.22; 95%CI: 1.06-9.81, P = 0.039). Patients exhibiting an NLR > 3.45 (p = 0.03) or a PLR> 189 (P = 0.005) did have a significantly worse CSS, while a HPR < 0.48 did not predict CSS (P = 0.12) on Kaplan Meier curves. Finally, an increased NLR (P = 0.047), increased PLR (P = 0.0006) and decreased HPR (P = 0.05) were all associated to a poor overall survival on univariate analysis. On multivariate analysis, only HPR remained significantly predictive of OS (HR 0.077; 95%CI: 0.02-0.37, P = 0.001).Conclusions. - In this single -center study analyzing non-metastatic RCC, an increased NLR was significantly associated to a reduced RFS, CSS and OS on univariate analyses and to RFS on multivariate analysis. Larger prospective studies are needed to validate our findings.
2019
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MEDS-14/C - Urologia
English
Albisinni, S., Pretot, D., Al Hajj Obeid, W., Aoun, F., Quackels, T., Peltier, A., et al. (2019). The impact of neutrophil-to-lymphocyte, platelet-to-lymphocyte and haemoglobin-to-platelet ratio on localised renal cell carcinoma oncologic outcomes|L'impact du rapport neutrophiles-lymphocytes, plaquettes-lymphocytes et hémoglobine-plaquettes sur les résultats oncologiques du carcinome rénal localisés. PROGRES EN UROLOGIE, 29(8-9), 423-431 [10.1016/j.purol.2019.05.008].
Albisinni, S; Pretot, D; Al Hajj Obeid, W; Aoun, F; Quackels, T; Peltier, A; Roumeguere, T
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S1166708719301174-main.pdf

solo utenti autorizzati

Tipologia: Versione Editoriale (PDF)
Licenza: Copyright dell'editore
Dimensione 854.08 kB
Formato Adobe PDF
854.08 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/404743
Citazioni
  • ???jsp.display-item.citation.pmc??? 12
  • Scopus 18
  • ???jsp.display-item.citation.isi??? 20
social impact